Veness Adam M

SVP, General Counsel and Sec.ACCELERON PHARMA INC (XLRN) · full profile →Form 4 · filed Sep 9, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$184K
Net Open-Market Flow
-$184K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 9, 2021Sell(S)1K$130.00$183K19K
Sep 8, 2021Sell(S)6$130.00$78020K
Sep 7, 2021Tax withholding(F)587$129.36$76K20K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001179110-21-008690) within minutes of acceptance. Every field above traces to the original document. Verify it directly: